| Chr | chr18 |
| start | 57054558 |
| end | 57072119 |
| lncRNA name | linc-ROR |
| entrez id | 100885779 |
| hgnc id | HGNC:43773 |
| ensg id | ENSG00000258609 |
| refseq id | NR_048536 |
| methods | qPCR etc. |
| regulated | down-regulated |
| function description | lincRNA-ROR was upregulated in TNBC cell lines and tissue samples.The aberrant expression of lincRNA-ROR was shown to increase invasion and metastasis in MDA-MB-231 and loss of function by siRNA reverse these process.Furthermore, lincRNA-ROR functions as a competing endogenous RNAs (ceRNA) which sponges miR-145 and therefore upregulate the expression of Mucin1 (MUC1).Studies showed that downregulated SPRY4-IT1 could facilitate bladder cancer cell apoptosis via acting as a ceRNA for miR-101-3p. |
| pubmed id | 29673594 |
| year | 2018 |
| title | LincRNA-RoR/miR-145 promote invasion and metastasis in triple-negative breast cancer via targeting MUC1. |
| drug | X |
| circulating | X |
| survival | X |
CopyRight © University of Miami, USA; Harbin Medical University, China